Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
814
datasets available to search
ShareScore release 0.9.0
Dataset results
814 results for “pancreatic adenocarcinoma”
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial
ClinicalTrials.gov study NCT06816914. IPD Sharing: NO. Countries: 1. Publications: 0.
Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05919238. IPD Sharing: NO. Countries: 1. Publications: 0.
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
ClinicalTrials.gov study NCT07348107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.
ClinicalTrials.gov study NCT03202199. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
ClinicalTrials.gov study NCT05475366. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT00728000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT04134468. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT04477343. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT06608927. IPD Sharing: YES. Countries: 13. Publications: 0.
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT04983407. IPD Sharing: NO. Countries: 1. Publications: 0.
Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05363007. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT06981806. IPD Sharing: NO. Countries: 1. Publications: 0.
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
ClinicalTrials.gov study NCT06673017. IPD Sharing: NO. Countries: 1. Publications: 0.
To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
ClinicalTrials.gov study NCT07303465. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT06893536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)
ClinicalTrials.gov study NCT01096732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT04809766. IPD Sharing: NO. Countries: 1. Publications: 0.
PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
ClinicalTrials.gov study NCT06815172. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT03080974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02368860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.